Puma Biotechnology, Inc. announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced total revenue was USD 98.169 million compared to USD 51.217 million a year ago. Operating income was USD 20.146 million compared to operating loss of USD 14.251 million a year ago. Net income was USD 16.528 million compared to net loss of USD 16.933 million a year ago. Basic earnings per share from continuing operations was USD 0.41 compared to basic loss per share from continuing operations of USD 0.43 a year ago. Diluted earnings per share from continuing operations was USD 0.4 compared to diluted loss per share from continuing operations of USD 0.43 a year ago.